Stone T W
Brain Res. 1986 Aug 27;381(1):195-8. doi: 10.1016/0006-8993(86)90713-4.
The active (-)-isomers of 2-amino-7-phosphonoheptanoic acid (2-APH) and 2-amino-5-phosphonopentanoic acid (2-APV) have been compared as antagonists of N-methyl-D,L-aspartate (NMDLA) and quinolinic acid on rat hippocampal slices. 2-APH appeared to be about 3 times more potent than 2-APV, though the same ratio was obtained against NMDLA and quinolinic acid. It is suggested that this difference of potency may partly explain the greater anticonvulsant activity of 2-APH. The results are consistent with the view that quinolinate acts at the NMDLA receptor while a differentiation between NMDLA and quinolinic acid is not likely to contribute to the anticonvulsant activities of 2-APH and 2-APV. A 3-fold difference of potency is also shown for (-)-2-APH and (-)-2-APV when blocking bicuculline-induced repetitive spikes in the CA1 region. This would support the involvement of an NMDLA receptor in this phenomenon.
已对2-氨基-7-膦酰庚酸(2-APH)和2-氨基-5-膦酰戊酸(2-APV)的活性(-)-异构体作为N-甲基-D,L-天冬氨酸(NMDLA)和喹啉酸对大鼠海马切片的拮抗剂进行了比较。2-APH的效力似乎比2-APV高约3倍,尽管对NMDLA和喹啉酸获得了相同的比例。有人认为,这种效力差异可能部分解释了2-APH更强的抗惊厥活性。结果与喹啉酸盐作用于NMDLA受体的观点一致,而NMDLA和喹啉酸之间的差异不太可能有助于2-APH和2-APV的抗惊厥活性。当阻断CA1区荷包牡丹碱诱导的重复放电时,(-)-2-APH和(-)-2-APV的效力也显示出3倍的差异。这将支持NMDLA受体参与这一现象。